Latest news with #pricing
News.com.au
3 hours ago
- Business
- News.com.au
Sydney pub slammed over ‘insane' price of steak special
A suburban Sydney pub has come under fire after a diner vented online about the price of a 'chef special' steak that they believed was 'taking the p*ss'. The customer took to the @r/foodies Reddit forum to share a photo of the menu at The Peakhurst, a premium pub in the St George Area, 25km southwest of the CBD. The pub's prime cut special was a 350g piece of Scotch Fillet with a Marble Score of 4+, which indicates a high-quality grade of beef. It's served with buttery mashed potato, roasted root vegetables and Cafe de Paris butter, and was priced at $90. $90 for a pub steak 'At my local, 90 bucks for a steak, not even a 'recommended for two' type thing,' the poster wrote to the forum. 'I don't mind paying a bit of coin at a hatted restaurant where you're getting the service and the ambience, but this is beyond taking the p*ss. I went with the gnocchi off the regular menu ($28).' They thought the pricing was particularly 'insane' considering the pub requires you to fetch your own cutlery. 'Ridiculous' Many commenters agreed, saying this was well above what they'd expect to pay for a pub chef's special. 'Pubs are getting pretty out there with prices, especially when you consider most of it is just meat/veg/veg,' one of the top comments read. 'Nothing that isn't shared should be $90,' another remarked. 'The pub special vs. a la carte is becoming stupid,' a third quipped. 'This is honestly ridiculous,' someone else commented, as others agreed it was a 'rip off'. However, others noted that 'It wouldn't be on the menu if it wasn't selling'. Pub responds to post A spokesman for The Peakhurst told that the venue seeks out high-quality suppliers for its monthly chef special steak. 'The producer of this cut of beef, Little Joe's, is a small farm, the animals are extremely well cared for, they have an extremely high marble score, and have won numerous awards for being some of the best beef in the world,' they said. 'And while people might be surprised to see a $90 steak in a pub, all pricing is done based on a Gross Profit (GP) Margin foruma. 'It's the cost of goods involved in producing that item. From that, you have GST to pay for, service staff to pay for, utilities, chefs, all your overheads – that all comes out from your GP, and that leaves you with your net profit. And everything is getting more and more expensive. 'We can't give away a product at less than the margins we need to keep our business open.' The spokesman acknowledged that while people come to pubs looking for value, there are four other cheaper steaks on the menu. 'If customers don't want a prime cut of beef, they can make a decision based on their own affordability,' they said. So, is this pricing really so out of order? A $90 steak special at a Peakhurst pub is objectively on the pricier side, considering it's generally considered a suburban, working-class suburb. It's also an outlier for any Sydney restaurant or pub, even in an affluent or gentrifying area. At Bistecca in Sydney's CBD, often hailed as the best steak restaurant in Sydney, steak costs $21 per 100 grams, meaning a 350g piece would be $73.50, well below The Peakhurst's $90. The Peakhurst's other four steaks, which range from 200-300g, average around $45.5, comparable to the prices at the most up-market pubs in Paddington, one of Sydney's most expensive suburbs, where the median house price is $3.5 million. At The Village Inn Paddington, a 250g steak is $42; at The Paddington, 250g is $45; and at the Paddo Inn, a 250g steak is $38. It's worth noting that beef pricing is surging in Australia at the moment, partly because of Donald Trump's crackdown on imports, with limited stock seeing prices soar. Costs have also gone through the roof for hospitality businesses recently. Nearly one in ten food service businesses closed in the past year amid rising rents, labour shortages, cost of labour and economic pressures, according to a recent report from CreditorWatch.
Yahoo
4 hours ago
- Business
- Yahoo
AstraZeneca seeks US drug price cuts amid expansion plans, strong demand
By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures pharmaceuticals companies to lower costs. Speaking to journalists after second-quarter revenue and profit beat expectations, CEO Pascal Soriot said Trump's administration was reviewing the company's proposals. He did not specify which drugs were included. Trump has repeatedly threatened tariffs as he also pushes drugmakers to reduce prices to what other countries pay. However, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any sector-specific levies take effect. "We definitely support the idea of rebalancing with some reduction of pricing levels in the U.S., and some increase, we're not talking about massive increases, in Europe," AstraZeneca's Soriot said. He added he expects all medicines for U.S. patients to be produced locally within a few months, and is also considering selling some medicines to customers directly. AstraZeneca shares rose as much as 3% after its results, but pared some gains to trade up 1.6% by 1214 GMT. "The big uncertainty, unsurprisingly, remains U.S. tariffs and Most Favoured Nation pricing in the pharmaceutical sector. AstraZeneca has looked to get ahead of this uncertainty," said Sheena Berry, a healthcare analyst at Quilter Cheviot. The U.S. accounted for more than 40% of AstraZeneca's revenue in 2024. The UK's largest-listed company by market value had prioritised the U.S. market - the world's largest, worth $635 billion - even before Trump's return to office. US BOOST AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease medicines drove total revenue for the second quarter 11% higher to $14.46 billion, on a constant currency basis. It logged double-digit growth in the U.S. despite headwinds from changes in U.S. Medicare price negotiations, while sales of cancer drugs including Tagrisso, Lynparza, Calquence, Truqap and Imfinzi beat expectations. Core earnings stood at $2.17 per share. Analysts were expecting $2.16, from $14.15 billion in sales, according to a company-provided consensus. AstraZeneca is betting on a wave of expected launches of 20 new medicines and its U.S. expansion to reach $80 billion in annual revenue by 2030 and offset generic competition. On Tuesday, it maintained its 2025 outlook and increased its interim dividend by 3%. The drugmaker in April forecast only a limited impact from potential U.S. tariffs, adding it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-U.S. trade deal over the weekend will result in a 15% tariff on most goods, including pharmaceuticals, from the region.
Android Authority
9 hours ago
- Business
- Android Authority
Leak reveals Pixel 10 prices, and they're exactly what we hoped for
TL;DR The prices for the entire Google Pixel 10 series have leaked. It appears there won't be any price increases this year. However, the Pixel 10 Pro XL may have a new starting price. A question we have long had about the Pixel 10 series is whether there will be a price hike. With the ongoing tariff situation, there seemed to be a good chance that we could see higher prices. Those fears may have been put to rest, however, after the most recent Pixel 10 leak. The prices of the entire Pixel 10 line may have been revealed in a new report from Android Headlines. The report provides prices for each storage option for every model. It even includes how much the series will cost in Canada. Here's what we can expect to pay: Pixel 10 128GB: $799 ($1,099 CAD) 256GB: $899 ($1,229 CAD) Pixel 10 Pro 128GB: $999 ($1,349 CAD) 256GB: $1,099 ($1,479 CAD) 512GB: $1,219 ($1,649 CAD) 1TB: $1,449 ($1,949 CAD) Pixel 10 Pro XL 256GB: $1,199 ($1,629 CAD) 512GB: $1,319 ($1,799 CAD) 1TB: $1,549 ($2,099 CAD) Pixel 10 Pro Fold 256GB: $1,799 ($2,399 CAD) 512GB: $1,919 ($2,569 CAD) 1TB: $2,149 ($2,869 CAD) The good news is that it looks like Google will be keeping the prices the same as last year. The bad news is that it appears the tech giant has dropped the 128GB version of the Pixel 10 Pro XL. That means the Pixel 10 Pro XL has a new starting price, despite the 256GB model costing the same as before. Along with a Pixel 10 purchase, the outlet says Google is offering up to six months of its AI Pro plan, six months of Fitbit Premium, and three months of YouTube Premium. This isn't the only Pixel 10 series news we received this week. Just a day ago, we were treated to a leak that revealed that the Pixel 10 series could have true Qi2 support. Google is expected to launch its next generation of Pixel devices on August 20. Follow
Phone Arena
14 hours ago
- Business
- Phone Arena
T-Mobile users say loyalty isn't just about price
Everyone's got their own reasons for picking a phone carrier – maybe it's the price, coverage, perks, or just how good the customer service is. T-Mobile, for example, has made a name for itself with aggressive pricing, which helped it grow into the $288 billion powerhouse it is today. Yep, despite all the online hate and drama, the Un-carrier keeps gaining ground faster than anyone else in the US wireless game. But what if price wasn't even part of the equation? Would people still stick with T-Mobile ? That's the exact question Redditors have been chewing on lately, and the answers give a pretty interesting peek into what really matters to customers. One big theme? International roaming. A lot of folks said global travel is the main reason they stick with T-Mobile instead of jumping to Verizon or AT&T. – woodsongtulsa, Reddit, July 2025 – chortle-guffaw2, Reddit, July 2025 – Interesting_Change_7, Reddit, July 2025 Of course, not everyone is in love with T-Mobile 's travel perks. Some users pointed out that Verizon actually offers more GB of high-speed data abroad on many of its plans, so it really depends on how much roaming you need and where you're headed. But international service isn't the only thing keeping people loyal. For many, T-Mobile just works best in the US, especially when it comes to true Verizon still wins in rural coverage, especilly when it comes to 4G, but T-Mobile takes the crown for fastest 5G in the country and offers solid service in most populated areas. – Any_Insect6061, Reddit, July 2025 T-Mobile is still leading when it comes to 5G coverage – first map is T-Mobile 5G, second Verizon 5G, third AT&T 5G. | Image credit – FCC – TraKat1219, Reddit, July 2025 Perks also play a big role. Things like Netflix on Us and satellite connectivity are enough to keep a lot of users from switching, even if the signal's not perfect everywhere. Still, a few commenters admitted they'd switch to Verizon or AT&T if money wasn't an issue – mainly for better rural coverage or more consistent customer support. Bottom line: if you are trying to decide whether to stay with T-Mobile or jump ship, it really comes down to what matters most to you. Do you care more about cool extras or do you want top-notch coverage no matter what it costs? Either way, this Reddit thread shows that loyalty in the wireless world is rarely about just one thing – it's a mix of features, experiences and good old-fashioned personal help choosing? Check out our carrier guides to find the best fit for you:
Reuters
15 hours ago
- Business
- Reuters
GSK in talks with Trump administration on U.S. drug pricing, CEO says
LONDON, July 30 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, becoming the latest pharmaceutical company to acknowledge action under pressure from Washington to rein in prices. GSK CEO Emma Walmsley said on a call with journalists after the company posted second-quarter profits above analyst expectations that the discussions with the U.S. administration are "about how to make sure discounts are passed on to patients and pricing is sustainable, both for the government and also for industry."
